Skip to NavigationSkip to content

Business Services

EUSA Pharma bolsters senior leadership team with two appointments

Published on: 15/05/19

Rare disease and oncology biopharma firm EUSA Pharma has revealed two new additions to its senior leadership team in two newly-created roles: Dr Carsten Thiel as President Europe and Dr Darrel P Cohen as Head of Clinical Development.

Paola Chiesi awarded honorary doctorate by Karolinska Institutet

Published on: 15/05/19

Paolo Chiesi, Vice President of the Chiesi Group, has been made an Honorary Doctor at the Karolinska Institutet – a research led medical university in Stockholm, Sweden.

Chiesi has been awarded an honorary degree in recognition of his long-standing commitment to the treatment of lung conditions in premature babies.

The ceremony, held in Blue Hall in Stockholm (the venue in which the annual Nobel Ceremony is held), took place on 10 May.

Ex-GSK, Novartis exec named as Mundipharma's Head of Access

Published on: 14/05/19

Mundipharma has announced that Jerome Moreau has joined the company as its new Head of Market Access.

Moreau has amassed experience in a range roles focusing on sales and marketing and later management and business development during his 25 years of experience in the pharma and biotechnology industry.

Most recently, he worked at GlaxoSmithKline as its Director, Global Market Access and Pricing. In the role, he was responsible for crafting and enacting a global strategy for access and pricing across the COPD franchise and local operating companies.

The interplay between the GDPR and the EU Clinical Trials Regulation

Published on 13/05/19 at 12:14pm

Paul Kavanagh, partner at law firm Dechert, explores the relationship between GDPR and CTR, and its potential impact on the legal implications of personal clinical trial data processing and handling.

Top Ten most popular articles on this week!

This week was a particularly bad one for the NHS after it was revealed thousands of EU nurses were leaving while the number of GPs had gone into decline for the first time in 50 years. Meanwhile our feature looked at the NHS Long Term Plan and asked to what extent mHealth will go towards solving the problems of the overstretched National Health Service.

Novartis buys dry eye treatment Xiidra in deal worth $5.3 billion

Japanese multinational Takeda Pharmaceutical has agreed to sell its dry eye drug Xiidra to Swiss firm Novartis in a deal worth as much as $5.3 billion.

Takeda has agreed to sell off Shire’s Xiidra for $3.4 billion upfront and as much as $1.9 billion in potential milestone payments.

The deal comes after Takeda’s acquisition of Shire catapulted the newly combined drugmaker into the top ten biggest pharmaceutical companies around the world.

Takeda now hopes to shed $10 billion worth of assets in an attempt to cut debt.

Mohammed Dar becomes third MedImmune exec to join Immunocore

Published on: 07/05/19

MedImmune’s Vice President of Clincial Development Oncology, Mohammed Dar has joined British biotech Immunocore as the company’s new CMO.

Dar is the third MedImmune executive to leave the AstraZeneca-subsidiary for Immunocore, after the head of MedImmune, Bahija Jallal, and the company’s Vice President, Translational Medicine Koustubh Ranade, joined Immunocore earlier this year.

ABPI names Novartis' Haseeb Ahmad as new President

Published on: 07/05/19

The Association of the British Pharmaceutical Industry (ABPI) has revealed the appointment of a new President: Haseeb Ahmad will assume the role with immediate effect.

He steps up from his current position of Managing Director, UK, Ireland & Nordics Novartis Pharmaceuticals and Country President at Novartis UK, to manage and oversee the organisation, its board and its Code of Practice, which is administered by the Prescription Medicines Code of Practice Authority (PMCPA). He fills the vacancy left by Erik Nordkamp.

Gilead's CFO and Executive Vice President to depart in 2020

Published on: 07/05/19

Gilead has announced that Robin Washington, the company’s Senior Vice President and Chief Financial Officer of more than a decade, has stepped down from her role.

Washington joined the company in 2008 as CFO, and was promoted to Executive Vice President in 2014. In her role, she oversees Gilead’s Global Finance and Information Technology organisations.

Will mobile phones save the NHS?

Published on 07/05/19 at 11:38am

The NHS is sick. According to politicians and NHS chiefs, the cure involves a strong dose of mHealth. Louis Goss asks to what extent mobile health apps can solve the problems of the increasingly strained health service.

Understaffed, underfunded and overstretched; Britain’s beloved National Health Service is under pressure like never before. As said succinctly in a parliamentary report from 2017: “Our NHS, our ‘national religion’, is in crisis and the adult social care system is on the brink of collapse.”

Mission Statement is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches